Skip to main content
SpringerLink
Log in

Adalimumab

Psoriasis like rash and lack of efficacy: 4 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ueno M, et al. Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes. Arthritis Research and Therapy 24: No. 1, 27 Oct 2022. Available from: URL: http://doi.org/10.1186/s13075-022-02934-3

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab. Reactions Weekly 1953, 15 (2023). https://doi.org/10.1007/s40278-023-37450-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-37450-5

Search

Navigation